PeptideDB

Orvepitant

CAS: 579475-18-6 F: C31H35F7N4O2 W: 628.62

Orvepitant (GW823296) is a compound with the ability to inhibit pruritus induced by cancer epidermal growth factor recep
Sales Email：peptidedb@qq.com
Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Orvepitant (GW823296) is a compound with the ability to inhibit pruritus induced by cancer epidermal growth factor receptor inhibitor (EGFRI) and is a neurokinin-1 receptor antagonist.
CAS 579475-18-6
Formula C31H35F7N4O2
Molar Mass 628.62
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Reference [1]. Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial

Mal-amido-PEG9-amine TFA

N-Me-Thalidomide-NH-C6-NH2

Product Recommendation

Latest release

Hot list

Copyright © 2025 PeptideDB All Rights Reserved

Sitemaps | Contact

Is for research use only, not for human use. We do not sell to patients.